Displaying 1 - 1 of 1
| Active Ingredient | ARTESUNATE |
| Therapeutic Class | ANTIMALARIALS |
| Indications | Malaria. Artesunate for Injection is indicated for the initial treatment of severe malaria in adult and pediatric patients. Treatment of severe malaria with Artesunate for Injection should always be f More ... |
| Caution | Gastrointestinal disturbances, pruritus and rash, dizziness, headache, tinnitus, neutropenia, elevated liver enzyme values, and ECG abnormalties including prolongation of the QT interval. |
| Dose Range | Oral: 4 mg/kg once daily , for 3 days. IM or IV: 2.4 mg/kg repeated after 12 and 24 hours and then once daily thereafter, transferring to an appropriate oral regimen after at least 24 hours. |
| Drug Interactions | |
| Pregnancy | Severe or complicated falciparum malaria is associated with a high risk of fatal More ... |
| Breast Feeding |